propafenone has been researched along with Actinic Reticuloid Syndrome in 1 studies
Propafenone: An antiarrhythmia agent that is particularly effective in ventricular arrhythmias. It also has weak beta-blocking activity.
propafenone : An aromatic ketone that is 3-(propylamino)propane-1,2-diol in which the hydrogen of the primary hydroxy group is replaced by a 2-(3-phenylpropanoyl)phenyl group. It is a class 1C antiarrhythmic drug with local anesthetic effects, and is used as the hydrochloride salt in the management of supraventricular and ventricular arrhythmias.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guindo, J | 1 |
| Rodriguez de la Serna, A | 1 |
| Borja, J | 1 |
| Oter, R | 1 |
| Jané, F | 1 |
| Bayés de Luna, A | 1 |
1 other study available for propafenone and Actinic Reticuloid Syndrome
| Article | Year |
|---|---|
Propafenone and a syndrome of the lupus erythematosus type.
Topics: Anti-Arrhythmia Agents; Female; Humans; Lupus Erythematosus, Systemic; Middle Aged; Photosensitivity | 1986 |